Yukiko Nishiuchi
Overview
Explore the profile of Yukiko Nishiuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iwamoto T, Arikawa K, Murase Y, Sekizuka T, Kuroda M, Nishiuchi Y, et al.
Infect Genet Evol
. 2023 Aug;
114:105495.
PMID: 37652282
Currently, tuberculosis (TB) in Japan is highly prevalent among elderly patients who were born during a time when TB was highly prevalent. Mycobacterium tuberculosis (Mtb) lineage 2 (L2) is the...
2.
Shaban A, Gebretsadik G, Hakamata M, Takihara H, Inouchi E, Nishiyama A, et al.
Sci Rep
. 2023 Aug;
13(1):14157.
PMID: 37644087
Survival of the live attenuated Bacillus Calmette-Guérin (BCG) vaccine amidst harsh host environments is key for BCG effectiveness as it allows continuous immune response induction and protection against tuberculosis. Mycobacterial...
3.
Komatsu T, Ohya K, Ota A, Nishiuchi Y, Yano H, Matsuo K, et al.
One Health
. 2023 Jun;
16:100559.
PMID: 37363238
subsp. (MAH) is one of the most prevalent mycobacteria causing non-tuberculous mycobacterial disease in humans and animals. Of note, MAH is a major cause of mycobacterial granulomatous mesenteric lymphadenitis outbreaks...
4.
Hou J, Fujiyoshi S, Perera I, Nishiuchi Y, Nakajima M, Ogura D, et al.
J Indian Inst Sci
. 2023 Jun;
:1-11.
PMID: 37362849
Supplementary Information: The online version contains supplementary material available at 10.1007/s41745-023-00380-x.
5.
Thapa J, Chizimu J, Kitamura S, Akapelwa M, Suwanthada P, Miura N, et al.
Microbiol Spectr
. 2023 Apr;
11(3):e0508822.
PMID: 37067420
Mycobacterium avium, a member of the M. avium complex (MAC), is the major pathogen contributing to nontuberculous mycobacteria (NTM) infections worldwide. Fluoroquinolones (FQs) are recommended for the treatment of macrolide-resistant...
6.
Komatsu T, Ohya K, Ota A, Nishiuchi Y, Yano H, Matsuo K, et al.
GigaByte
. 2023 Feb;
2021:gigabyte33.
PMID: 36824340
subsp. (MAH) is one of the most important agents causing non-tuberculosis mycobacterial infection in humans and pigs. There have been advances in genome analysis of MAH from human isolates, but...
7.
Perera I, Fujiyoshi S, Nishiuchi Y, Nakai T, Maruyama F
Microbiol Immunol
. 2022 Sep;
66(12):564-578.
PMID: 36128640
Bacteria in general interact with zooplankton in aquatic ecosystems. These zooplankton-bacterial interactions help to shape the bacterial community by regulating bacterial abundances. Such interactions are even more significant and crucially...
8.
Nishiuchi Y, Tateishi Y, Hirano H, Ozeki Y, Yamaguchi T, Miki M, et al.
Microbiol Spectr
. 2022 Mar;
10(2):e0245421.
PMID: 35293805
Pathogenic intracellular mycobacteria, such as Mycobacterium tuberculosis and Mycobacterium avium, which cause lung diseases, can grow in macrophages. Extracellular mycobacteria have been reported in the lungs, blood, and sputum of...
9.
Akapelwa M, Kapalamula T, Ouchi-Aizu Y, Hangombe B, Nishiuchi Y, Gordon S, et al.
Diagn Microbiol Infect Dis
. 2021 Aug;
101(4):115494.
PMID: 34391980
Early detection and treatment are paramount for the timely control of Mycobacterium avium infections. Herein, we designed a LAMP assay targeting a widely used species-specific marker IS1245 for the rapid...
10.
Nishiuchi Y
Microbes Environ
. 2021 Feb;
36(1).
PMID: 33597330
Mycobacterium avium subsp. hominissuis (MAH) is one of the most common nontuberculous mycobacterial pathogens responsible for chronic lung disease in humans. It is widely distributed in biofilms in natural and...